ENV
0.003
50%
LUX
0.23
-31.3%
DAL
0.105
40%
NGX
0.051
-27.1%
ARO
0.004
33.3%
LIB
0.003
-25%
EDE
0.084
29.2%
EGR
0.23
-20.7%
GLL
0.005
25%
FEL
0.004
-20%
BOA
0.19
22.6%
SRJ
0.004
-20%
CMO
0.006
20%
EXR
0.061
-19.7%
SEA
1.85
18.2%
IBX
0.006
-14.3%
FMN
0.14
16.7%
PNT
0.006
-14.3%
AUV
0.008
14.3%
AAU
0.007
-12.5%
KZR
0.16
14.3%
NOV
0.014
-12.5%
CXZ
0.025
13.6%
SKS
9.79
-12.4%
CMD
0.018
12.5%
A4N
0.582
-11.8%
GAS
0.01
11.1%
ERL
0.008
-11.1%
MLS
0.02
11.1%
KRM
0.019
-9.5%
BKT
0.011
10%
TR2
0.3
-9.1%
FRM
0.275
10%
IIQ
0.155
-8.8%
PKO
0.011
10%
ECT
0.105
-8.7%
AEU
0.395
9.7%
LSA
0.105
-8.7%
H2G
0.012
9.1%
3DA
0.16
-8.6%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

LBT Innovations (ASX: LBT): Completes first sale of APAS® PharmaQC

Australian medical technology company LBT Innovations (ASX: LBT) has completed its first sale of APAS® PharmaQC to Thermo Fisher Scientific (Thermo Fisher), aiming to provide efficiencies and improve traceability within environmental monitoring workflows using AI | ASX announcement: https://announcements.asx.com.au/asxpdf/20240222/pdf/060pf49b9csjfg.pdf